Description: Naratriptan is a triptan class of agents that is mainly used for the treatment of migraine headaches. Naratriptan is marketed by GlaxoSmithKline and is available in 2.5 mg tablets. The mechanism of action for Naratriptan is to act as a selective 5-HT1 receptor subtype agonist. Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light.

References: J Headache Pain. 2011 Aug;12(4):399-403.

Related CAS: 121679-13-8 (free base); 143388-64-1 (HCl); 1190021-64-7 (Naratriptan D3)

纯度：≥98%

CAS：121679-13-8